September is Childhood Cancer Awareness Month, an observance recognized by health care institutions, advocacy organizations, patients and families around the world. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents, according to the National Cancer Institute. Acute Lymphoblastic Leukemia (ALL)…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Cystic Fibrosis
- Parkinson’s Disease
- Health Disparities
- Personalized Medicine
- Hepatitis C
- Secondary Progressive MS
- Macular Degeneration
People with acute lymphoblastic leukemia (ALL) may have a range of treatment options available to them, including chemotherapy, targeted therapy, immunotherapy, surgery and radiation therapy. These options will vary depending on the patient’s ALL subtype, age, state of health and other prognostic factors. A patient’s cancer care team may also…more.
If you or someone you love has Alzheimer’s disease, your search for treatments or a cure may lead you to consider a range of unproven remedies. To be clear, there are medications, treatments and strategies that can slow declines and help people with the disease have the highest possible quality…more.
Childhood cancer survivorship is a journey. Survivors and their families need to be prepared for life after cancer, and the National Children’s Cancer Society (NCCS) is committed to them every step of the way. Real World Health Care recently interviewed NCCS’s Jessica Cook, MSW, vice president of Patient & Family…more.
Access to health care and the opportunity to achieve optimal health should not depend on where people live, their socioeconomic status, or their race and ethnicity, but as the COVID-19 pandemic has shown, that is not always the case. COVID-related disparities served to shine a light on other areas of…more.
Throughout 2022, Real World Health Care is covering the issue of racial and ethnic health disparities. This week, we explore the topic through the lens of gout, a type of arthritis that has a higher prevalence among racial and ethnic minorities, especially Blacks, than whites. Michael Spigler, vice president of…more.
Studies have shown that cancer disproportionately impacts racial and ethnic minority groups, however, these groups remain underrepresented in cancer clinical trials.1,2,3 With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (ACCC) recently developed consensus-driven recommendations to improve diversity, equity and accessibility in cancer research.…more.
Social determinants of health (SDOH) have long-term, far-reaching, and not always obvious ramifications in people’s lives, including their risk for Alzheimer’s disease and related dementias (ADRD). These disparities were made clear by a 2020 report issued by UsAgainstAlzheimer’s and the Urban Institute. The report found that deep social inequities –…more.
First identified in 1989, the hepatitis C virus (HCV) kills thousands of people in the United States each year. An estimated 2.4 million Americans live with chronic hepatitis C infection, which if left untreated can result in serious, even life-threatening health problems like cirrhosis and liver cancer. While HCV knows…more.
More than 9.2 million Americans live with gout, but only 10 percent of people with gout are getting the ongoing treatment they need. The lack of proper treatment is particularly acute among Black patients, who have a 25 percent higher prevalence of the disease but are much less likely to…more.